May 12, 2010 - Increased detection and treatment of abdominal aortic aneurysms (AAAs) and peripheral arterial disease (PAD) will drive the U.S. peripheral vascular device market to over $5.3 billion by 2016, according to a new report by iData Research.
The U.S. peripheral vascular device market is worth $2.8 billion. The stent-graft and peripheral vascular stent segments will lead growth is in the market.
Nearly two million people have aortic aneurysms in the U.S., but only 20% of cases are detected. If left untreated, approximately one-third of AAAs will rupture, causing death in 75 to 90 percent of patients. Improved AAA screening will also lead to increased detection of thoracic aortic aneurysms (TAAs).
The report states that the market for peripheral stents, used for treating PAD, has seen strong double-digit growth since 2005, and is expected to grow much faster than the coronary stent market through 2016.
iData's global three-report series on the "Markets for Peripheral Vascular Devices 2010" covers stents, PTA balloon catheters, atherectomy devices, CTO devices, stent-grafts, surgical-grafts, AV access thrombectomy devices, inferior-vena-cava-filters, catheters, guidewires, introducer sheaths and VCDs.
For more information: www.idataresearch.net/idata/registration.php
December 14, 2017 
